Oligometastatic Prostate Cancer

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. [Phase 3]

  An open-label Phase 3 trial comparing Lutetium-177Lu vipivotide tetraxetan to observation in PSMA-positive oligometastatic prostate cancer i…

• CLINICAL_TRIALS research · 2026-01-20
  Clinical Trial Update: SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma [Phase 3]

  A Phase 3 clinical trial compares SBRT versus hypofractionated radiotherapy for biochemically recurrent or oligometastatic prostate cancer; …

• CLINICAL_TRIALS research · 2025-12-26
  Clinical Trial Update: Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

  A clinical trial is evaluating percutaneous thermo-ablation as a treatment for oligometastatic prostate cancer. The study is currently not r…

• CLINICAL_TRIALS research · 2025-12-08
  Clinical Trial Update: HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) [NA]

  This entry outlines the HIMARS trial evaluating highly metastatic life-prolonging therapy with stereotactic radiotherapy for bone and lymph …

• CLINICAL_TRIALS research · 2025-08-20
  Clinical Trial Update: Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer [NA]

  The trial compares comprehensive radiotherapy to primary-tumor radiotherapy for oligometastatic prostate cancer and is currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-04-26
  Clinical Trial Update: Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) [Phase 2]

  Phase 2 trial SEGNO is exploring genomic biomarker-guided neoadjuvant therapy for locally advanced or oligometastatic prostate cancer; recru…